•  
  •  
 

Abstract

Introduction. The proper of antibiotics treatment will increase the improvement of the patient with community-acquired pneumonia (CAP) and also counteract antimicrobial resistance. Community-Acquired Pneumonia is commonly found in Indonesia with an incidence of 2.4%. This study aimed to determine the proper of antibiotic selection for CAP based on IDSA-ATS 2007 guidelines with Gyssens method and evaluate the relationship between the proper of antibiotic treatment with the clinical response of patients. Methods. A retrospective cohort study was conducted with secondary data from the previous study. Study was conducted in three hospitals in Jakarta, namely Cipto Mangunkusumo General Hospital, Budhi Asih Hospital, and Gatot Subroto Hospital between September 2016 and November 2017. Results. From 151 patients, the appropriate of the first antibiotic treatment, including category 0 and 1 was found in 38 patients (25.2%), while for inappropriate one (category II-V) was in 113 patients (74.8%) mainly due too short antibiotic treatment. For the second antibiotic given to 54 patients, appropriate treatment was found in 15 patients (9.9%). There was no correlation between the accuracy of both antibiotics treatment in CAP based on Gyssens method with clinical response of the patients (first antibiotic treatment: RR=0,970 (95% CI: 0,80 – 1,16), p=0,738; second antibiotic treatment: RR=1,194 (95% CI: 0,648 – 2,20), p=1,00). Conclusion. There was no correlation between the accuracy of antibiotics treatment in CAP based on Gyssens method with clinical response of the patients.

References

1. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72. 2. Badan Penelitian dan Pengembangan Kesehatan. Riset kesehatan dasar 2013. Jakarta: Kementerian Kesehatan RI; 2013. 3. Yacovo DS, Vidal CG, Viasus D, Adamus J, Oriol I, Gili F, et al. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with diabetes mellitus. Medicine (Baltimore). 2013:92(1):42-50. 4. Jain S, Self WH, Wunderink RG, Fakhran S, Balk S, Bramley AM, et al. Community-acquired pneumonia requiring hospitalization among U.S adults. N Engl J Med. 2015;373(5):415–27. 5. Farida H, Gasem MH, Suryanto A, Keuter M, Zulkarnain N, Satoto B, et al. Viruses and gram-negative bacilli dominate the etiology of community-acquired pneumonia in Indonesia, a cohort study. Int J Infect Dis. 2015;38:101–7. 6. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in adults. Thorax. 2009;64(Suppl 3):iii1 –55. 7. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, et al. Guidelines for the management of adult lower respiratory tract infections. Clin Microb Infect. 2011;17(s6):E1–59. 8. Mahmudah FA, Sri S, Hartini S. Studi penggunaan antibiotik berdasarkan ATC/DDD dan DU 90% di bagian bedah digestif salah satu RS di Bandung. J Farmasi Klinik Indonesia. 2016;5(4):293-8. 9. Kementerian Kesehatan RI. Peraturan Kementrian Kesehatan Republik Indonesia No: 2406 / Menkes / XII/ 2011 tentang pedoman umum penggunaan antibiotik. Jakarta: Kemenkes RI; 2011. 10. World Health Organization (WHO). Bibliography of scientific publication on antimicrobial resistence from South- East Asia Region 1990-2010. New Delhi, India: Mahatma Gandhi Marg; 2011. p.1-286. 11. Kourkouta L, Kotslftopoulos CH, Papageorglou M, Illadis CH, Monlos A. The rational use of antibiotics medicine. J Healthcare Com. 2017;2(3):1-4. 12. Gyssens, IC, van den Broek, PJ, Kullberg, BJ, Hekster, Y, and van der Meer, JW. Optimizing antimicrobial therapy. A method for antimicrobial drug use evaluation. J Antimicrob Chemother. 1992; 30: 724–727 13. Kunin, CM, Tupasi, T, and Craig, WA. Use of antibiotics. A brief exposition of the problem and some tentative solutions. Ann Intern Med. 1973;79(4):555–60. 14. Dewi NT, Mutmainah N. Naskah Publikasi Kajian Penggunaan Antibiotik pada Pasien Pneumonia dengan metode Gyssens di Balai Kesehatan X Surakarta tahun 2012-2013. Universitas Muhammadiyah Surakarta. 2014 15. Sumiwi AS. Kualitas penggunaan antibiotik pada pasien bedah digestif di salah satu Rumah Sakit di Bandung. J Farmasi Klinik Indonesia. 2014;3(4):135-40. 16. Firmansyah M, Amin Z, Loho T, Shatri H. Faktor-faktor prediktor mortalitas community acquired pneumonia dalam perawatan inap di Rumah Sakit Ciptomangunkusumo, Jakarta. Indonesia Journal of CHEST Critical and Emergency Medicine. 2015;2(2):45-53. 17. Dertarani V, Nugroho TL, Lestari ES. Evaluasi penggunaan antibiotik berdasarkan kriteria gyssens pasien rawat inap kelas III di bagian bedah RSUP Dr. Kariadi [Tesis]. Semarang: Fakultas Kedokteran Universitas Diponegoro; 2009. 18. Sitompul F, Radji M, Bahtiar A. Evaluasi penggunaan antibiotik dengan metode gyssens pada pasien stroke rawat inap di RSUD Koja secara retrospektif (periode KJS dan BPJS). J Kefarmasian Indonesia. 2016;6(1):30-8. 19. Etienne P, Roger P, Brofferio P, Labate C, Blanc V, Tiger F, et al. Antimicrobial stewardship program and quality of antibiotic prescription. Med Mal Infect. 2011;41(11):608-12. 20. Takahashi K, Suzuki M, Minh LN, Anh NN, Huong LTM, Son TVV, et al. The incidence and aetiology of hospitalized community-acquired pneumonia pneumonia among Vietnamese adults: a prospective surveillance in Central Vietnam. BMC Infect Dis. 2013;13:296. 21. Ishiguro T, Takayanagi N, Yamaguchi S, Yamakawa H, Nakamoto K, Takako Y, et al. Etiology and factors contributing to the severity and mortality of community acquired pneumonia. Intern Med. 2013;52:317-24. 22. Braeken DCW, Rohde GGU, Franssen FME, Driessen JHM, Staa TPV, Souverein PSC, et al. Risk of community acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom. Int J Chron Obstruct Pulmon Dis. 2017;12: 2425-32. 23. Jones BE, Jones J, Bewick T, Lim WS, Aronsky D, Brown SM, et al. CURB-65 pneumonia severity assesment adapted for electronic decision support. Chest. 2011;140(1):156-63. 24. Marti C, Garin N, Grosgurin O, Poncet A, Combescure C, Carballo S, et al. Prediction of severe community acquired pneumonia: a systematic review and meta-analysis. Crit Care. 2012;16(4):2-12. 25. Fadillah U, Hasmono D, Wibisono YA, Melinda M. Antibiogram study and antibiotic use evaluation using gyssen method in patients with diabetic foot. Folia Medica Indonesiana. 2016;52(3):198-208. 26. Tyas MW, Suprapti B, Hardiono, Widodo ADW. Analysis of antibiotic use in VAP (ventilator-association pneumonia) patients. Folia Medica Indonesiana. 2013;49(3):168-72. 27. Adani SD, Zulfariansyah A, Teesa P. Quality assesment of antibiotic prescription for sepsis treatment in intensive care unit at top referral hospital in West Java, Indonesia. Althea Medical J. 2017;4(2):286-92.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.